Table 2.
Subject | Age (y) | Sex | BMI | Type | Size (cm) | Location |
---|---|---|---|---|---|---|
1 | 56 | M | 47.4 | HCC | 4.7 | Segment 3 |
2 | 52 | F | 23.0 | HCC | 2.0 | Segment 5/6 |
3 | 55 | M | 24.4 | NET | 6.3 | Segment 6 |
4* | 60 | F | 27.3 | HCC | 3.4 | Segment 5 |
5 | 58 | M | 25.8 | HCC | 2.4 | Segment 5 |
6 | 43 | F | 25.0 | NET | 6.0 | Segment 6/7 |
7 | 64 | F | 22.4 | NET | 4.1 | Segment 4B |
8* | 60 | F | 27.3 | HCC | 4.5 | Segment 5 |
9 | 60 | M | 32.5 | HCC | 3.4 | Segment 5/6 |
10 | 73 | M | 21.7 | NET | 6.0 | Segment 6 |
11 | 63 | M | 24.4 | HCC | 5.3 | Segment 6 |
Tumor types consisted of neuroendocrine tumors (NET) and hepatocellular carcinomas (HCC). Tumor size is indicated as the largest measured diameter.
*Same patient.